Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Maurer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
EMBO Reports|August 4, 2009
Before it's too late. Why synthetic biologists need an open-parts collaboration--and how to build oneStephen M Maurer
Future Medicinal Chemistry|May 21, 2013
Open source drug collaborations: a rational design approachStephen M Maurer
Bulletin of the World Health Organization|May 20, 2006
Choosing the right incentive strategy for research and development in neglected diseasesStephen M Maurer
Nature Biotechnology|December 17, 2009
Parts, property and sharingJoachim Henkel, Stephen M Maurer
Molecular Systems Biology|June 7, 2007
The economics of synthetic biologyJoachim Henkel, Stephen M Maurer
Nature Biotechnology|January 12, 2010
Harmonizing biosecurity oversight for gene synthesisMarkus Fischer, Stephen M Maurer
Plos Medicine|January 5, 2005
Finding cures for tropical diseases: is open source an answer?Stephen M Maurer, Arti Rai, Andrej Sali
Journal of Fungi (Basel, Switzerland)|September 28, 2021
Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid LeukemiaAnastasia I Wasylyshyn, Kathleen A Linder, Carol A Kauffman, et al.
Bone Marrow Transplantation|September 23, 2022
Infectious complications after second allogeneic hematopoietic cell transplant in adult patients with hematological malignanciesStephen M Maurer, Kathleen A Linder, Carol A Kauffman, et al.
Breast Cancer Research and Treatment|March 8, 2017
Breast cancer screening in patients with cancers other than breastRobin B Leopold, Alexander W Thomas, Kyle F Concannon, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
EMBO Reports|August 4, 2009
Before it's too late. Why synthetic biologists need an open-parts collaboration--and how to build oneStephen M Maurer
Future Medicinal Chemistry|May 21, 2013
Open source drug collaborations: a rational design approachStephen M Maurer
Bulletin of the World Health Organization|May 20, 2006
Choosing the right incentive strategy for research and development in neglected diseasesStephen M Maurer
Nature Biotechnology|December 17, 2009
Parts, property and sharingJoachim Henkel, Stephen M Maurer
Molecular Systems Biology|June 7, 2007
The economics of synthetic biologyJoachim Henkel, Stephen M Maurer
Nature Biotechnology|January 12, 2010
Harmonizing biosecurity oversight for gene synthesisMarkus Fischer, Stephen M Maurer
Plos Medicine|January 5, 2005
Finding cures for tropical diseases: is open source an answer?Stephen M Maurer, Arti Rai, Andrej Sali
Journal of Fungi (Basel, Switzerland)|September 28, 2021
Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid LeukemiaAnastasia I Wasylyshyn, Kathleen A Linder, Carol A Kauffman, et al.
Bone Marrow Transplantation|September 23, 2022
Infectious complications after second allogeneic hematopoietic cell transplant in adult patients with hematological malignanciesStephen M Maurer, Kathleen A Linder, Carol A Kauffman, et al.
Breast Cancer Research and Treatment|March 8, 2017
Breast cancer screening in patients with cancers other than breastRobin B Leopold, Alexander W Thomas, Kyle F Concannon, et al.
Pageof 2